Exploring the effect of Duffy status on patients with breast cancer receiving cyclin-dependent kinase 4/6 inhibitors.
Saved in:
| Title: | Exploring the effect of Duffy status on patients with breast cancer receiving cyclin-dependent kinase 4/6 inhibitors. |
|---|---|
| Authors: | Ferri GM; Section of General Internal Medicine, Department of Medicine, Boston Medical Center, 72 East Concord Street, Boston, MA, 02118, USA. gferri@bu.edu., Martinez CB; Section of General Internal Medicine, Department of Medicine, Boston Medical Center, 72 East Concord Street, Boston, MA, 02118, USA., Acevedo J; Section of Hematology/Oncology, Boston Medical Center, Boston, MA, USA., Bhatt S; Department of Pharmacy, Boston Medical Center, Boston, MA, USA., Verma KP; Section of Hematology/Oncology, Boston Medical Center, Boston, MA, USA., Lee J; Department of Biostatistics, Boston University School of Public Health, Boston, MA, USA., Abdallah M; Section of Hematology/Oncology, Boston Medical Center, Boston, MA, USA., Szalat RE; Section of Hematology/Oncology, Boston Medical Center, Boston, MA, USA., Sloan JM; Section of Hematology/Oncology, Boston Medical Center, Boston, MA, USA. |
| Source: | Breast cancer research and treatment [Breast Cancer Res Treat] 2025 Dec 12; Vol. 215 (1), pp. 36. Date of Electronic Publication: 2025 Dec 12. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Kluwer Academic Country of Publication: Netherlands NLM ID: 8111104 Publication Model: Electronic Cited Medium: Internet ISSN: 1573-7217 (Electronic) Linking ISSN: 01676806 NLM ISO Abbreviation: Breast Cancer Res Treat Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
